Skip to content
The Nexus
DossierENTITY

Health Resources and Services Administration

Coverage of Health Resources and Services Administration in the Nexus archive.

Earliest in view: May 14 · 14:00 UTCMost recent: Aug 6 · 12:30 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHAug 6 · 12:30 UTCBUSINESS INSIDER
    The states with the worst and best healthcare, ranked

    WalletHub analyzed factors including cost, access, and outcomes to rank the best and worst states for healthcare in the US across all 50 states and D.C. The analysis relied on data compiled by multiple institutions, noting that New Hampshire was found to have the best healthcare while Alaska ranked lowest overall.

  • HEALTHJul 31 · 17:02 UTCSTAT NEWS
    STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

    The Trump administration revised a pilot for the 340B Drug Pricing Program, allowing pharmaceutical companies to offer rebates instead of upfront discounts. The change, effective Jan. 1, 2027, targets drugs and companies involved in Medicare Drug Price Negotiation Program rounds, angering hospitals and clinics.

  • BUSINESSJul 18 · 09:30 UTCFORTUNE
    Indeed chief economist: Aging Baby Boomers are America’s real labor problem, not AI

    The US labor force is projected to shrink by nearly 6 million workers by 2032 due to aging Baby Boomers retiring faster than younger generations can replace them, with healthcare, construction, and skilled trades facing severe shortages. While AI concerns dominate discussions, the article argues the real challenge is demographic shifts, as sectors reliant on human labor struggle to fill roles despite slower job markets in AI-exposed industries.

  • HEALTHJul 14 · 19:57 UTCSTAT NEWS
    STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year

    Sales under the U.S. 340B Drug Discount Program reached $100 billion in 2025, a 22.8% increase from the previous year. Expensive medicines accounted for 62% of spending, with Merck’s Keytruda and Gilead Sciences’ Biktarvy being the top two drugs by spending. The program requires drugmakers to offer 25-50% discounts to hospitals and clinics serving lower-income patients.

  • HEALTHMay 14 · 14:00 UTCFOX NEWS
    New federal probe examines whether taxpayer dollars fund child gender transitions, legal defenses

    Senator Bill Cassidy is investigating whether taxpayer dollars are funding child gender transitions and legal defenses for healthcare providers. The probe examines two Rhode Island health care providers and federal funding for community health centers. Cassidy demands answers on reports of providing puberty blockers and cross-sex hormones to minors.

  • HEALTHMay 14 · 14:00 UTCFOX NEWS POLITICS
    New federal probe examines whether taxpayer dollars fund child gender transitions, legal defenses

    Senator Bill Cassidy is investigating whether taxpayer dollars are funding child gender transitions and legal defenses for healthcare providers. The probe examines federally supported health providers in Rhode Island, including Thundermist Health Center and Hasbro Children’s Hospital. The senator is seeking answers on the use of federal funds for gender transition-related services to minors.